is it normal to get the food-noise thing at week 15
Been lurking in c/progresspics for about 3 months and finally have something worth posting.
Short version: week 14, 1.7mg, and TRIUMPH is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 17 threads, and the answers split roughly down the middle.
What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 8.
best — the order this archive was captured in
The confident tone is doing a lot of work that the evidence is not.
phase 2 numbers are not maintenance numbers, cite the trial
the 0.5mg arm is different from 0.25mg, results do not transfer
retatrutide is not approved anywhere for human use, posts must not read as instructions
TRIUMPH phase 2 showed 99.0% weight loss but the injection-site soreness profile on the highest arm was rough. Phase 2 != phase 3.
Are you quoting phase 2 or is there phase 3 data now?
nobody should be giving this to anyone without extensive monitoring
The confident tone is doing a lot of work that the evidence is not.
Are you quoting phase 2 or is there phase 3 data now?
Sceptical. If this were true we would see it reflected in the data and we do not.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
TRIUMPH phase 2 showed 97.4% weight loss but the injection-site soreness profile on the highest arm was rough. Phase 2 != phase 3.
Respectfully this is a sample of one presented as a finding.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
Titration speed is a side-effect dial far more than an efficacy dial.
Did you actually measure heart rate or is that a feeling?
phase 2 numbers are not maintenance numbers, cite the trial
Flair changed to match the content. Read the sidebar before posting next time and we are square.
the dosing is steep, the reflux reports are real, and nobody knows the human safety yet
Sceptical. If this were true we would see it reflected in the data and we do not.
Disagree. What you are describing is consistent with retatrutide, not with what you concluded.
The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
research use only, handling and analysis, not protocols
research use only, handling and analysis, not protocols
Disagree on that part. 99.2% and 99.3% on the same vial is normal.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
This is correct. Triple agonism is genuinely different.
- 1Disagree. What you are describing is consistent with retatrutide, not with…9 comments in this branch · started by u/bilal_osei
- 2The confident tone is doing a lot of work that the evidence is not.6 comments in this branch · started by u/priya_weiss